AOXING PHARMACEUTICAL COMPANY, INC. - FORM 10-K - EX-23 - CONSENT OF BDO SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS - October 5, 2016

Attached files

file filename
EX-32.2 - CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.exh32_2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.exh31_1.htm
EX-10.2 - 2016 STOCK INCENTIVE PLAN - AOXING PHARMACEUTICAL COMPANY, INC.exh10_2.htm
EX-21.1 - LIST OF SUBSIDIARIES - AOXING PHARMACEUTICAL COMPANY, INC.exh21_1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - AOXING PHARMACEUTICAL COMPANY, INC.exh31_2.htm
EX-32.1 - CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. - AOXING PHARMACEUTICAL COMPANY, INC.exh32_1.htm
10-K - 10K - AOXING PHARMACEUTICAL COMPANY, INC.aoxing.htm
Exhibit 23


 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No.333-205148) and Form S-8s (No. 333-177641) of Aoxing Pharmaceutical Company, Inc. and its subsidiaries of our reports dated October 5, 2016, relating to the consolidated financial statements, which appears in this Annual Report on Form 10-K for the fiscal year ended June 30, 2016 filed with the Securities and Exchange Commission.




BDO CHINA SHU LUN PAN Certified Public Accountants LLP

October 5, 2016



AOXING PHARMACEUTICAL COMPANY, INC. Reports